58 research outputs found
Atlanta Youth Count 2018 Community Report: The Prevalence of Sex and Labor Trafficking Among Homeless Youth in Metro Atlanta
The 2018 Atlanta Youth Count (AYC18) was a follow-up study to the 2015 Atlanta Youth Count and Needs Assessment (AYCNA), expanded in 2018 to specifically address sex and labor trafficking among youth experiencing homelessness in metro Atlanta. The goals of this project were to: 1) provide metro Atlanta service providers, policymakers, and youth advocates with practical information on the size, nature, and needs of the homeless, precariously housed, and runaway youth in our community who are involved in various forms of sex and labor trafficking; 2) collect information that can be used to develop and refine policies, programs, and interventions to help these youth in our community; and 3) encourage a community-wide dialogue about the needs and social determinants of youth homelessness and human trafficking. This study was funded by the National Institute of Justice and was conducted in partnership with local service providers, advocates, researchers, and students.
This document is the official public Human Trafficking Report and provides an overview of the study methodology and key findings, including the research teamās official estimates of the prevalence of trafficking among homeless youth in metro Atlanta, as well as a description of key characteristics of the population derived from the survey data collected. Members of the research team are continuing to analyze and use the data to improve the publicās and policymakersā understanding of youth homelessness and trafficking and to guide community - based efforts to improve services for these young people
Risk Communication, Values Clarification, and Vaccination Decisions
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/115958/1/risa12418.pd
Differential Mechanisms of Septic Human Pulmonary Microvascular Endothelial Cell Barrier Dysfunction Depending on the Presence of Neutrophils
Sepsis is characterized by injury of pulmonary microvascular endothelial cells (PMVEC) leading to barrier dysfunction. Multiple mechanisms promote septic PMVEC barrier dysfunction, including interaction with circulating leukocytes and PMVEC apoptotic death. Our previous work demonstrated a strong correlation between septic neutrophil (PMN)-dependent PMVEC apoptosis and pulmonary microvascular albumin leak in septic mice in vivo; however, this remains uncertain in human PMVEC. Thus, we hypothesize that human PMVEC apoptosis is required for loss of PMVEC barrier function under septic conditions in vitro. To assess this hypothesis, human PMVECs cultured alone or in coculture with PMN were stimulated with PBS or cytomix (equimolar interferon Ī³, tumor necrosis factor Ī±, and interleukin 1Ī²) in the absence or presence of a pan-caspase inhibitor, Q-VD, or specific caspase inhibitors. PMVEC barrier function was assessed by transendothelial electrical resistance (TEER), as well as fluoroisothiocyanate-labeled dextran and Evans blue-labeled albumin flux across PMVEC monolayers. PMVEC apoptosis was identified by (1) loss of cell membrane polarity (Annexin V), (2) caspase activation (FLICA), and (3) DNA fragmentation [terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)]. Septic stimulation of human PMVECs cultured alone resulted in loss of barrier function (decreased TEER and increased macromolecular flux) associated with increased apoptosis (increased Annexin V, FLICA, and TUNEL staining). In addition, treatment of septic PMVEC cultured alone with Q-VD decreased PMVEC apoptosis and prevented septic PMVEC barrier dysfunction. In septic PMNāPMVEC cocultures, there was greater trans-PMVEC macromolecular flux (both dextran and albumin) vs. PMVEC cultured alone. PMN presence also augmented septic PMVEC caspase activation (FLICA staining) vs. PMVEC cultured alone but did not affect septic PMVEC apoptosis. Importantly, pan-caspase inhibition (Q-VD treatment) completely attenuated septic PMN-dependent PMVEC barrier dysfunction. Moreover, inhibition of caspase 3, 8, or 9 in PMNāPMVEC cocultures also reduced septic PMVEC barrier dysfunction whereas inhibition of caspase 1 had no effect. Our data demonstrate that human PMVEC barrier dysfunction under septic conditions in vitro (cytomix stimulation) is clearly caspase-dependent, but the mechanism differs depending on the presence of PMN. In isolated PMVEC, apoptosis contributes to septic barrier dysfunction, whereas PMN presence enhances caspase-dependent septic PMVEC barrier dysfunction independently of PMVEC apoptosis
Porous hydroxyapatite-bioactive glass hybrid scaffolds fabricated via ceramic honeycomb extrusion
The successful fabrication of hydroxyapatiteābioactive glass scaffolds using honeycomb extrusion is presented herein. Hydroxyapatite was combined with either 10 wt% stoichiometric BioglassĀ® (BG1), calciumāexcess BioglassĀ® (BG2) or canasite (CAN). For all composite materials, glassāinduced partial phase transformation of the HA into the mechanically weaker Ī²ātricalcium phosphate (TCP) occurred but XRD data demonstrated that BG2 exhibited a lower volume fraction of TCP than BG1. Consequently, the maximum compressive strength observed for BG1 and BG2 were 30.3 Ā± 3.9 and 56.7 Ā± 6.9 MPa, respectively, for specimens sintered at 1300Ā°C. CAN scaffolds, in contrast, collapsed when handled when sintered below 1300Ā°C, and thus failed. The microstructure illustrated a morphology similar to that of BG1 sintered at 1200Ā°C, and hence a comparable compressive strength (11.4 Ā± 3.1 MPa). The results highlight the great potential offered by honeycomb extrusion for fabricating highāstrength porous scaffolds. The compressive strengths exceed that of commercial scaffolds, and biological tests revealed an increase in cell viability over 7 days for all hybrid scaffolds. Thus it is expected that the incorporation of 10 wt% bioactive glass will provide the added advantage of enhanced bioactivity in concert with improved mechanical stability
Major Depressive Disorder in College Students
This literature review examines major depressive disorder symptoms, pathology, risk factors, protective factors, medications, and resources with a focus on Midwest college students
data_sheet_1_Differential Mechanisms of Septic Human Pulmonary Microvascular Endothelial Cell Barrier Dysfunction Depending on the Presence of Neutrophils.PDF
<p>Sepsis is characterized by injury of pulmonary microvascular endothelial cells (PMVEC) leading to barrier dysfunction. Multiple mechanisms promote septic PMVEC barrier dysfunction, including interaction with circulating leukocytes and PMVEC apoptotic death. Our previous work demonstrated a strong correlation between septic neutrophil (PMN)-dependent PMVEC apoptosis and pulmonary microvascular albumin leak in septic mice in vivo; however, this remains uncertain in human PMVEC. Thus, we hypothesize that human PMVEC apoptosis is required for loss of PMVEC barrier function under septic conditions in vitro. To assess this hypothesis, human PMVECs cultured alone or in coculture with PMN were stimulated with PBS or cytomix (equimolar interferon Ī³, tumor necrosis factor Ī±, and interleukin 1Ī²) in the absence or presence of a pan-caspase inhibitor, Q-VD, or specific caspase inhibitors. PMVEC barrier function was assessed by transendothelial electrical resistance (TEER), as well as fluoroisothiocyanate-labeled dextran and Evans blue-labeled albumin flux across PMVEC monolayers. PMVEC apoptosis was identified by (1) loss of cell membrane polarity (Annexin V), (2) caspase activation (FLICA), and (3) DNA fragmentation [terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)]. Septic stimulation of human PMVECs cultured alone resulted in loss of barrier function (decreased TEER and increased macromolecular flux) associated with increased apoptosis (increased Annexin V, FLICA, and TUNEL staining). In addition, treatment of septic PMVEC cultured alone with Q-VD decreased PMVEC apoptosis and prevented septic PMVEC barrier dysfunction. In septic PMNāPMVEC cocultures, there was greater trans-PMVEC macromolecular flux (both dextran and albumin) vs. PMVEC cultured alone. PMN presence also augmented septic PMVEC caspase activation (FLICA staining) vs. PMVEC cultured alone but did not affect septic PMVEC apoptosis. Importantly, pan-caspase inhibition (Q-VD treatment) completely attenuated septic PMN-dependent PMVEC barrier dysfunction. Moreover, inhibition of caspase 3, 8, or 9 in PMNāPMVEC cocultures also reduced septic PMVEC barrier dysfunction whereas inhibition of caspase 1 had no effect. Our data demonstrate that human PMVEC barrier dysfunction under septic conditions in vitro (cytomix stimulation) is clearly caspase-dependent, but the mechanism differs depending on the presence of PMN. In isolated PMVEC, apoptosis contributes to septic barrier dysfunction, whereas PMN presence enhances caspase-dependent septic PMVEC barrier dysfunction independently of PMVEC apoptosis.</p
- ā¦